HER2/neu Testing in Breast Carcinoma. Concordance Study Fluorescent In Situ Hybridization (FISH) vs. Chromogenic In Situ Hybridization (CISH)

被引：0
|
作者：
Elavathil, L.
Dhesy, B.
Wiernikowski, J.
Browning, D.
Akhtar-Danesh, N.
Hanna, W.
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
[3] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
160
引用
收藏
页码：38A / 38A
页数：1
相关论文
共 50 条
  • [41] Comparison of HER2 status determination methods in HER2 (2+) patients: Manual fluorescent in situ hybridization (FISH) vs. dual silver enhanced in situ hybridization (SISH)
    Pehlivanoglu, Burcin
    Serin, Gurdeniz
    Yeniay, Levent
    Zekioglu, Osman
    Gokmen, Erhan
    Ozdemir, Necmettin
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2017, 31 : 36 - 40
  • [42] Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas
    Rosa, F. E.
    Santos, R. M.
    Rogatto, S. R.
    Domingues, M. A. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2013, 46 (03) : 207 - 216
  • [43] Correlation between HER2/neu protein overexpression on Immunohistochemistry and Fluorescent in Situ Hybridization (FISH) in breast carcinoma: Problems in developing countries
    Mukhtar, Zubaria
    Faisal, Amina
    Mudassir, Ghazala
    Mamoon, Nadira
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (06) : 1814 - 1817
  • [44] HER2 amplification through CISH -chromogenic hybridization in situ- on breast cancer Her 2 2+by immunohistochemistry -ICH
    Bella, S. R.
    Lerda, D.
    Guidi, A.
    Theaux, R.
    Armando, L.
    Sambuelli, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens
    Lin, F
    Shen, T
    Prichard, JW
    DIAGNOSTIC CYTOPATHOLOGY, 2005, 33 (06) : 376 - 380
  • [46] Chromogenic in situ hybridization analysis of HER-2/neu status in cytological samples of breast carcinoma
    Kim, GY
    Oh, YL
    CYTOPATHOLOGY, 2004, 15 (06) : 315 - 320
  • [47] CHROMOGENIC AND FLUORESCENT IN SITU HYBRIDIZATION ANALYSIS OF HER-2/NEU (CERB-B2) EXPRESSION IN FINE NEEDLE ASPIRATION SAMPLES OF BREAST CARCINOMA: A PILOT STUDY COMPARING FISH, CISH AND IMMUNOCYTOCHEMISTRY
    Kapila, K.
    Francis, I.
    George, S.
    Al-Awadhi, S.
    Al-Mulla, F.
    ACTA CYTOLOGICA, 2010, 54 (03) : 499 - 500
  • [48] Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Mayr, Doris
    Heim, Sibylle
    Weyrauch, Kerstin
    Zeindl-Eberhart, Evelyn
    Kunz, Anne
    Engel, Jutta
    Kirchner, Thomas
    HISTOPATHOLOGY, 2009, 55 (06) : 716 - 723
  • [49] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [50] Automatic quantification of HER2 amplification in invasive breast cancer using chromogenic in situ hybridization (CISH) and computational pathology
    Hossain, M. S.
    Nakamura, T.
    Hanna, M.
    Uraoka, N.
    Ross, D. S.
    Hameed, R.
    Yamaguchi, M.
    Yagi, Y.
    VIRCHOWS ARCHIV, 2019, 475 : S18 - S18
12345